Equally important, it would require annual reports to Congress on clinical outcomes, research and success from innovative therapies so we could evaluate what works and establish those best practices Department-wide.
Require the Department of Veterans Affairs to submit annual reports to Congress on clinical outcomes, research, and success of innovative therapies for veterans.
Occurrences
Evidence
On March 27, 2026, Senator Tim Sheehy introduced the bipartisan Veterans Health Administration Novel Therapeutics Preparedness Act. This legislation aims to establish a dedicated Office of Novel Therapeutics within the Department of Veterans Affairs (VA) to enhance veterans' access to innovative health care. A key provision of the bill requires the VA to submit annual reports to Congress detailing clinical outcomes, research, and the success of emerging therapies for veterans.
04-30-2026 | S.4220 | Veterans Health Administration Novel Therapeutics Preparedness Act | Latest Action: Committee on Veterans' Affairs. Hearings held.
Mr. Sheehy (for himself, Mr. Gallego, Ms. Duckworth, and Mr. Boozman) introduced the following bill; which was read twice and referred to the Committee on Veterans' Affairs.
Assessments
Sheehy introduced S.4220, the Veterans Health Administration Novel Therapeutics Preparedness Act, during his current Senate term, and the bill includes the promised annual VA reporting requirement on clinical outcomes, research, and success of innovative therapies. However, the measure has not been enacted and the requirement is not in force; the latest available status shows committee activity only. This is a serious legislative attempt by the candidate, so it merits an effort badge, but not delivery of the promised outcome.
Senator Sheehy introduced legislation that would require the VA to submit annual reports on clinical outcomes and therapies, reflecting a serious attempt to deliver on the promise. However, there is no evidence the bill became law or that the requirement was enacted, so the outcome was not delivered despite significant legislative effort.